This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wednesday's ETF Winners & Losers

Exchange-traded funds tracking semiconductors were among the worst performers Wednesday, after a bearish analyst report on expected chip prices and Micron Technology's (MU) disappointing quarter.

Micron was sliding nearly 9% after swinging to a fiscal fourth-quarter loss, while Merrill Lynch initiated coverage of Intel (INTC), Advanced Micro Devices (AMD) and Nvidia (NVDA) with underweight ratings.

The Ultra Semiconductor ProShares (USD) was shedding $3.71, or 4.1%, to $87.58. The Semiconductor HOLDRs (SMH) was losing 89 cents, or 2.23, to $38.07. The iShares S&P GSTI Semiconductor (IGW) was off $1.49, or 2.2%, to $67.53.

Funds tracking Chinese markets also were among the losers. Hong Kong's Hang Seng index lost 719.81 points overnight.

The iShares FTSE/Xinhua China 25 Index (FXI) was losing $11.09, or 5.9%, to $178.40. The SPDR S&P China (GXC) was shedding $5.67, or 5.8%, to $92.94. The PowerShares Golden Dragon Halter USX China (PGJ) was off $1.61, or 4.6%, to $33.21.

Funds tracking homebuilders were among the session's few winners, as several holdings continued their run-up a second day. Beazer Homes (BZH), Standard Pacific (SPF) and Brookfield Homes (BHS) were all up more than 3.5%.

The iShares Dow Jones US Home Construction (ITB) was gaining 60 cents, or 2.7%, to $22.46. The iShares FTSE NAREIT Residential (REZ) was adding 79 cents, or 1.7%, to $48.70.

Biotech- and pharmaceutical-related funds also were among the winners. Arena Pharmaceuticals (ARNA), Imclone Systems (IMCL) and Genzyme (GENZ) were all adding more than 3%.

The SPDR S&P Biotech (XBI) was gaining $1.01, or 1.7%, to $59.56. The Ultra Health Care ProShares (RXL) was tacking on 75 cents, or 1%, to $74.70. The Pharmaceutical HOLDRs (PPH) was adding 74 cents, or 0.9%, to $81.82.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
FXI $51.92 0.00%
GXC $98.40 0.00%
ITB $26.98 0.00%
PPH $72.58 0.00%
PGJ $33.89 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs